4[3]Lamb HM,Figgitt DP, Faulds D. Quinupristin-dalfopristin. A review of its use in the management of serious gram-positive infections. Drugs, 1999; 58: 1061.
5[4]Barriere JC, Berthaud N. Recent developments in streptogramin research. Curr, Pharm Des, 1998; 4: 155.
6[5]Chu DTW. Recent progress in novel macrolides, quinolones and 2-pyridones to overcome bacterial resistance. Med Res Rev,1999, 19: 497.
7[6]Bricker S J, Hutchinson DK, Barbachyn MR, et al. Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant Gram- positive bacterial infections. J Med Chem, 1996; 39: 673.
8[7]Barbachyn MR, Hutchinson DK, Bricker SJ, et al. Identification of a novel oxazolidinoe (U-100480) with potant antimycoba cterial activity J Med Chem, 1996; 39: 680.
9[8]Clemett D, Markham A. Linezolide, Drugs,2000;59:815.
10[10]Gadwood RC, Shinabarger DA. Progress in the oxazolidinone antibacterials . Annu Rep Med Chem, 2000; 35: 135.
3Bonfiglio,G.,G.Russo,and G.Nicoletti,Recent Developments in Carbapenems[J].Expert Opin Investig Drugs,2002,11(4):529-44.
4Pfeifer,Y.,A.Cullik,and W.Witte.Resistance to Cephalosporins and Carbapenems in Gram-Negative Bacterial Pathogens[J].Int J Med Microbiol.300(6):p.371-9.
5Credito,K.K.Kosowska-Shick,and P.C.Appelbaum,Mutant Prevention Concentrations of Four Carbapenems against Gram-Negative Rods.Antirnicrob Agents Chemother[J].54(6):2692-5.
6Bowker K E,:Hols H A,Rccves D S.Bactericidal activity postantibiotic effect and modified controlled effective regowth time of meropenem at high concentrations[J].J Antimicrob Chemother,1996,38(6):1055
7Ronald N J,Holly K H,Biedenbach D J,et al.Doripenem (S-4661),a novel carbapenem:comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations[J].J Antimicrob Chemother,2004,54:144
8Yoshiaki K,Masako O,Takeshi N.Antibacterial properties of BO-2727,a new carbapenem antibiotic[J].J Antimicrob Chenmother,1997,40:195
9Thomson K S,Moland S.CS-023(R-115685),a novel carbapenem with enhanced in vitro activity against oxacillin-resistant staphylococci and Pseudomonas aeruginosa[J].J Antimicrob Chemothcr,2004,54(2):557
10Shuichi M,Takayuki H,Nobuhiko F.In vitro andin vivo antibacterial activities of 1-084,a novel oral carbapenem,against causative organisms of respiratory tract infections[J].Antimicrob Agents Chemother,2001,45(1):203
